Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Longitudinal Evaluation of Quality of Life and Fatigue In Hodgkin Lymphoma Patients

Peter Borchmann, MD, Horst Müller, Corinne Brillant, Karolin Behringer, Teresa Halbsguth, MD, Volker Diehl, Hans Henning Flechtner, Andreas Engert, MD

Blood (2010) 116 (21): 935.

https://doi.org/10.1182/blood.V116.21.935.935

Published: 2010

Journal Articles

“Quality of Life (QoL) in the Randomised HD10-12 Trials of the German Hodgkin Study Group (GHSG): Sexual Functions (SX) in Hodgkin Lymphoma (HL) Patients Decrease by Disease Stage and Improve After Therapy Depending On Stage and Treatment Modality.”.

Karolin Behringer, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Teresa Halbsguth, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, MD, Peter Borchmann

Blood (2009) 114 (22): 896.

https://doi.org/10.1182/blood.V114.22.896.896

Published: 2009

Journal Articles

Escalated BEACOPP Versus ABVD-Like Chemotherapy for Hodgkin Lymphoma Patients: a Cochrane Review.

Corinne Brillant, Kathrin Bauer, Christine Herbst, MD, MPH, Ina Monsef, Nicole Skoetz, Andreas Engert, MD

Blood (2009) 114 (22): 3705.

https://doi.org/10.1182/blood.V114.22.3705.3705

Published: 2009

Journal Articles

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Julia Bohlius, MD, MScPH, Corinne Brillant, Michael Clarke, DPhil, Sabine Kluge, Maryann Napoli, Margaret Piper, PhD, MPH, Dirk Rades, MD, PhD, Martin Schumacher, PhD, Kurt Schmidlin, Guido Schwarzer, PhD, Jerome Seidenfeld, MSc, PhD, David P. Steensma, MD, FACP, Sven Trelle, Olaf Weingart, MD, Marcel Zwahlen, Matthias Egger, MD, MSc, Andreas Engert, MD

Blood (2008) 112 (11): 4675.

https://doi.org/10.1182/blood.V112.11.4675.4675

Published: 2008

Journal Articles

Quality of Life in a 2-Year Follow-up: Signs of PNP Predicting Cognitive Functioning in Survivors Treated in the HD10–12 Trials of the German Hodgkin Study Group (GHSG).

Teresa Halbsguth, Horst Mueller, Hans-Henning Flechtner, Corinne Brillant, Karolin Behringer, Thomas Schober, Hiltrud Nisters-Backes, Andreas Engert, Peter Borchmann

Blood (2008) 112 (11): 1455.

https://doi.org/10.1182/blood.V112.11.1455.1455

Published: 2008

Journal Articles

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Julia Bohlius, MD, MScPH, Corinne Brillant, Michael Clarke, PhD, Sabine Kluge, Maryann Napoli, Margaret Piper, PhD, MPH, Dirk Rades, MD, PhD, Isabelle Ray-Coquard, MD, Kurt Schmidlin, MD, MPH, Martin Schumacher, PhD, Guido Schwarzer, PhD, Jerome Seidenfeld, MSc, PhD, David P. Steensma, MD, FACP, Sven Trelle, MD, Michael Untch, MD, Olaf Weingart, MD, Marcel Zwahlen, PhD, Matthias Egger, MD, MSc, Andreas Engert, MD

Blood (2008) 112 (11): lba-6.

https://doi.org/10.1182/blood.V112.11.lba-6.lba-6

Published: 2008

Journal Articles

Chemotherapy Alone Versus Chemotherapy Plus Radiotherapy for Early Stage Hodgkin Lymphoma.

Fareed A. Rehan, Corinne Brillant, Holger Schulz, Ina Knauel, Julia Bohlius, Lena Specht, Andreas Engert

Blood (2007) 110 (11): 2320.

https://doi.org/10.1182/blood.V110.11.2320.2320

Published: 2007

Journal Articles

Differences in Survival Rates for Patients with Hodgkin Lymphoma, Who Were Treated Inside vs. Outside Therapy Optimisation Protocols in Germany.

Corinne Brillant, Claudia Terschueren, Sylke Gierer, Jeremy Franklin, Stephanie Heidelbach, Ursula Paulus, Volker Diehl, Wolfgang Hoffmann

Blood (2007) 110 (11): 2321.

https://doi.org/10.1182/blood.V110.11.2321.2321

Published: 2007

Journal Articles

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

Lucia Nogova, MD, Thorsten Reineke, Corinne Brillant, Thomas Ruediger, Prof, Hans K. Mueller-Hermelink, Prof., Henning Bredenfeld, MD, Andreas Josting, MD, Rolf P. Mueller, Prof., Volker Diehl, Prof., Andreas Engert, Prof.

Blood (2006) 108 (11): 97.

https://doi.org/10.1182/blood.V108.11.97.97

Published: 2006

Journal Articles

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

Volker Diehl, Corinne Brillant, Andreas Engert, Ralf-Peter Mueller, Hans-Theodor Eich, Konrad Mueller-Hermelink, Richard Herrmann, Jana Markova, Anthony Ho, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Josting, Beate Pfistner

Blood (2005) 106 (11): 816.

https://doi.org/10.1182/blood.V106.11.816.816

Published: 2005

Journal Articles

Comparison of Hematopoietic Reconstitution after Autologous Transplantation Using Stem Cells after Short- (<12 Months) and Longer-Term Cryostorage.

Raymond M. Lowenthal, MD, Kate L. Burbury, MBBS (Hons), DPhil, Scott J. Ragg, PhD, Corinne Brillant

Blood (2005) 106 (11): 5498.

https://doi.org/10.1182/blood.V106.11.5498.5498

Published: 2005

NARROW

Longitudinal Evaluation of Quality of Life and Fatigue In Hodgkin Lymphoma Patients

“Quality of Life (QoL) in the Randomised HD10-12 Trials of the German Hodgkin Study Group (GHSG): Sexual Functions (SX) in Hodgkin Lymphoma (HL) Patients Decrease by Disease Stage and Improve After Therapy Depending On Stage and Treatment Modality.”.

Escalated BEACOPP Versus ABVD-Like Chemotherapy for Hodgkin Lymphoma Patients: a Cochrane Review.

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Quality of Life in a 2-Year Follow-up: Signs of PNP Predicting Cognitive Functioning in Survivors Treated in the HD10–12 Trials of the German Hodgkin Study Group (GHSG).

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

Chemotherapy Alone Versus Chemotherapy Plus Radiotherapy for Early Stage Hodgkin Lymphoma.

Differences in Survival Rates for Patients with Hodgkin Lymphoma, Who Were Treated Inside vs. Outside Therapy Optimisation Protocols in Germany.

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

Comparison of Hematopoietic Reconstitution after Autologous Transplantation Using Stem Cells after Short- (<12 Months) and Longer-Term Cryostorage.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only